Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
Table 2
Baseline characteristics of 219 HIV-infected patients with prevalent TB, incident TB, and no TB.
Characteristics
Prevalent TB (unrecognized) ()
Incident TB ()
No TB ()
Age (yrs), mean (SD)
38.5 (5.3)
38.3 (9.2)
36.4 (8.2)
Gender (Female) (%)
4 (67)
6 (75)
143 (70)
BMI (kg/m2), median (IQR)
18.8 (16.6–19.7)*
19.1 (17.9–21.2)**
22.8 (20.4–25.7)
CD4 counts (cell/μL), median (IQR)
131 (60–168)
103 (23–140)
131 (67–172)
Haemoglobin (g/dL), mean (SD)
11.9 (1.9)
10.5 (1.4)**
12.4 (1.9)
C-reactive protein (mg/dL), median (IQR)
24.9 (11.6–31.5)**
19.4 (3.9–51.3)*
2.2 (1.0–6.0)
TST positive at ART start (%)
4 (67)
1 (25)
59 (30)
ART: antiretroviral therapy; BMI, body mass index; IQR: interquartile range; SD: standard deviation; TB: tuberculosis; TST: tuberculin skin test. -values: *, ** compared with the no TB group.
